Akura Medical has enrolled the first subject in the multi-centre QUADRA-PE trial, which is assessing its flagship Katana ...
Key barriers in adhering to anticoagulation guidelines included uncertainty about its choice, established practices, and the ...
Akura Medical, Inc., a privately held portfolio company of Shifamed LLC that is developing treatments for venous thromboembolis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback